We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Immunoassay Screens Risky Malaria Blood Donations

By LabMedica International staff writers
Posted on 22 Aug 2013
An enzyme-linked immunosorbent assay (ELISA) has been used to screen blood donations in an area highly endemic for malaria. More...


The main causative agent of malaria, Plasmodium falciparum, poses a threat on critical transfusions for road accident victims, pregnancy-related hemorrhages and child anemia enhancing the risk of transfusion-transmitted malaria (TTM).

Scientists at the University of Strasbourg (Alsace, France) collected blood in ethylenediaminetetraacetic acid (EDTA) tubes from 2,515 voluntary blood donors in Benin, over a period of 10 months, from May 2009 and March 2010. Microscopic examination was used to count parasites and parasite density (PD) was expressed as the number of parasites per µL of blood.


The plasmodium lactate dehydrogenase (pLDH) antigen detection was performed by a sandwich ELISA notably an ELISA-malaria antigen test (apDianv; Turnhout, Belgium) that detects pLDH via immunocapture. The apDia Antigen ELISA is an in vitro diagnostic immunoassay (IVD) for the qualitative determination of Plasmodium spp. Antibody screening was performed using a homemade ELISA-antibody test.


Among the 2,025 males and 488 females screened, the rate of asymptomatic Plasmodium carriage was 295/2,515 (11.7%). Males had a higher infection rate of 12.4% than did females at 8.8%. Parasite density was very low with between seven and100 parasites per µL of blood reported in 80% of donors with parasitaemia. Three malaria species were diagnosed: P. falciparum in 280/295 patients (95.0%), Plasmodium malariae in 14/295 (5.0%), and Plasmodium ovale in 1/295 (0.34%). The use of a highly sensitive assay enabled pan Plasmodium pLDH detection in 966/2,515 (38.4%) and malaria antibody prevalence was found in 1,859/2,515 (73.9%).


The authors concluded that detection of the pLDH antigen seems to be an adequate screening tool in endemic areas, for this antigen indicates parasite presence. Routine screening of all donated blood would prevent infected blood donations and reduce P. falciparum transmission in critical patients, such as children and pregnant women. This tool would also decrease medical prophylaxis in donation recipients and contribute to lower Plasmodium resistance. One drawback was that if the donors had taken self-treatment measures prior to blood donation, malaria infection was masked and pLDH detection failed. The study was published on August 8, 2013, in the Malaria Journal.

Related Links:
University of Strasbourg
apDia


New
Gold Member
Automatic Hematology Analyzer
CF9600
Online QC Software
Acusera 24•7
New
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]
New
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Roche’s CE-Marked Elecsys pTau217 blood test is a single‑assay blood test measures phosphorylated tau 217, an indicator of amyloid pathology and a hallmark of Alzheimer’s disease (image credit: Shutterstock)

Blood-Based Alzheimer’s Test Gains CE Mark for Amyloid Pathology Detection

Alzheimer’s disease is the most common cause of dementia, yet confirmatory testing remains invasive and hard to access. Diagnosis currently takes an average of 3.5 years, and about 75% of people with dementia... Read more

Molecular Diagnostics

view channel
Image: Clarifying tumor microenvironment features and cancer-cell programs linked to treatment response could provide earlier insight into triple-negative breast cancer therapy (image credit: Shutterstock)

Gene Panel Shows Promise for Predicting Chemotherapy Response in TNBC

Triple-negative breast cancer (TNBC) is an aggressive subtype commonly treated with chemotherapy, yet outcomes vary widely among patients. Understanding the tumor features that drive this variability remains... Read more

Microbiology

view channel
Image: The initiative combines epidemiological and microbiological data with whole-genome sequencing to characterize circulating hospital lineages and resistance determinants (image credit: Shutterstock)

Large-Scale Genomic Surveillance Tracks Resistant Bacteria Across European Hospitals

Antimicrobial resistance (AMR) poses a growing threat to patient safety, with carbapenem-resistant Enterobacterales causing difficult-to-treat infections and leaving clinicians with limited therapeutic options.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.